Showing results (301-310 of 308) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 308 results.
Journal of the American College of Radiology : JACR|May 7, 2021
ACR Appropriateness Criteria® Seizures-Child, Anna Trofimova, Sarah S Milla, et al.
Rheumatology (Oxford, England)|February 3, 2026
The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus studyJoanne Ablewhite, Georgina Nakafero, Abdullah Almayahi, et al.
Cancer Discovery|December 6, 2011
Characterization of KRAS rearrangements in metastatic prostate cancerXiao-Song Wang, Sunita Shankar, Saravana M Dhanasekaran, et al.
Hormones (Athens, Greece)|July 20, 2026
EndoBridge 2025: pearls and highlightsBulent Okan Yildiz, Mirco Armenti, Maria Luisa Brandi, et al.
Rheumatology Advances in Practice|October 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scopeStephanie F Ling, Joshua L Bennett, Vanessa J Reid, et al.
Rheumatology Advances in Practice|July 15, 2024
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scopeLouise Mercer, Abhishek Abhishek, Akhila Kavirayani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 29, 2021
Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXASMarcela A Ferrada, Keith A Sikora, Yiming Luo, et al.
American Journal of Human Genetics|September 2, 2022
Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapiesCharli E Harlow, Josan Gandawijaya, Rosemary A Bamford, et al.
Pageof 31